Filing Details
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:EWTX
Edgewise Therapeutics, Inc. (EWTX) Files Quarterly Report for Q0
Filing Details Edgewise Therapeutics, Inc. (NASDAQ:EWTX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026. The Healthcare…
Market Context
Edgewise Therapeutics, Inc.'s stock currently trades at $44.42 with a market capitalization of $2.5B.
The 10-Q provides Edgewise Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Edgewise Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View EWTX Stock Page
Frequently Asked Questions
Where can I read EWTX's SEC filings?
Browse all filings on our EWTX SEC filings page.
What types of SEC filings does Edgewise Therapeutics, Inc. file?
Public companies like Edgewise Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
